State PA
Clinical Trials in Pennsylvania
Recruiting clinical trials with at least one study location in Pennsylvania. Data updated daily from ClinicalTrials.gov.
Top Conditions in Pennsylvania
NCT05063331 N/A
Recruiting
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
Condition
Uterine Prolapse
Enrollment
320 pts
Location
United States
Sponsor
University Hospitals Cleveland
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
NCT07154823 N/A
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients ...
Condition
Acute Myeloid Leukaemia (AML)
Enrollment
550 pts
Location
United States
Sponsor
Tempus AI
NCT06271694 N/A
Recruiting
Activity and Participation in Vestibular Disorders
Condition
Vestibular Disorder
Enrollment
67 pts
Location
United States
Sponsor
University of Pittsburgh
NCT05101551 Phase 1
Recruiting
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML ...
Condition
Acute Myeloid Leukemia
Enrollment
34 pts
Location
United States
Sponsor
Norman J. Lacayo
NCT06325202 N/A
Recruiting
Closed Loop and Education for Hypoglycemia Awareness Restoration
Condition
Diabetes Mellitus, Type 1
Enrollment
324 pts
Location
United States, Australia, United Kingdom
Sponsor
Milton S. Hershey Medical Cent
NCT05871970 Phase 2
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic...
Condition
Lymphatic Malformation
Enrollment
38 pts
Location
United States
Sponsor
Protara Therapeutics
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.
NCT06839456 Phase 1, Phase 2
Recruiting
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infectio...
Condition
Leukemia
Enrollment
100 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT05956951 N/A
Recruiting
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia P...
Condition
Schizophrenia
Enrollment
200 pts
Location
United States
Sponsor
Fabio Ferrarelli
NCT04572451 Phase 1
Recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metasta...
Condition
Melanoma
Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT07126886 Phase 4
Recruiting
A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Me...
Condition
Pressure Ulcer
Enrollment
100 pts
Location
United States
Sponsor
Applied Biologics, LLC
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
NCT04250857 N/A
Recruiting
HeartStart FRx Defibrillator Event Registry
Condition
Sudden Cardiac Arrest
Enrollment
1,400 pts
Location
United States
Sponsor
Philips Clinical & Medical Aff
NCT00307281 N/A
Recruiting
Emphysema Research Registry and Biosample Repository
Condition
Emphysema
Enrollment
3,000 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT06441331 Phase 1
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium L...
Condition
Somatostatin Receptor Positive
Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
NCT04187131 N/A
Recruiting
An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabil...
Condition
Stroke
Enrollment
10 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06666439 N/A
Recruiting
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastat...
Condition
Metastatic Invasive Lobular Carcinoma (mILC)
Enrollment
20 pts
Location
United States
Sponsor
Julia Foldi
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences
NCT05734066 Phase 1, Phase 2
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants Wit...
Condition
Refractory Ewing Sarcoma
Enrollment
60 pts
Location
United States, Canada
Sponsor
Jazz Pharmaceuticals